BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14534842)

  • 1. Evolving complexity of open aortofemoral reconstruction done for occlusive disease in the endovascular era.
    Back MR; Johnson BL; Shames ML; Bandyk DF
    Ann Vasc Surg; 2003 Nov; 17(6):596-603. PubMed ID: 14534842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary outcomes of thoracofemoral bypass.
    Crawford JD; Scali ST; Giles KA; Back MR; Fatima J; Arnaoutakis DK; Berceli SA; Upchurch GJ; Huber TS
    J Vasc Surg; 2019 Apr; 69(4):1150-1159.e1. PubMed ID: 30292606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease.
    Dosluoglu HH; Lall P; Cherr GS; Harris LM; Dryjski ML
    J Vasc Surg; 2010 Jun; 51(6):1425-1435.e1. PubMed ID: 20488323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Femorofemoral bypass for aortofemoral graft limb occlusion: a ten-year experience.
    Nolan KD; Benjamin ME; Murphy TJ; Pearce WH; McCarthy WJ; Yao JS; Flinn WR
    J Vasc Surg; 1994 May; 19(5):851-6; discussion 856-7. PubMed ID: 8170039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the iliac artery a suitable inflow conduit for iliofemoral occlusive disease: an analysis of 514 aortoiliac reconstructions.
    Darling RC; Leather RP; Chang BB; Lloyd WE; Shah DM
    J Vasc Surg; 1993 Jan; 17(1):15-9; discussion 19-22. PubMed ID: 8421331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary comparison of aortofemoral bypass to alternative inflow procedures in the Veteran population.
    McPhee JT; Madenci A; Raffetto J; Martin M; Gupta N
    J Vasc Surg; 2016 Dec; 64(6):1660-1666. PubMed ID: 27462000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimal inflow procedure for multi-segmental occlusive arterial disease: ilio-femoral versus aorto-bifemoral bypass.
    Zukauskas G; Ulevicius H; Janusauskas E
    Cardiovasc Surg; 1998 Jun; 6(3):250-5. PubMed ID: 9705096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A personal experience with direct reconstruction and extra-anatomic bypass for aortoiliofemoral occlusive disease.
    Hertzer NR; Bena JF; Karafa MT
    J Vasc Surg; 2007 Mar; 45(3):527-535; discussion 535. PubMed ID: 17321340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limb-threatening ischemia due to multilevel arterial occlusive disease. Simultaneous or staged inflow/outflow revascularization.
    Harward TR; Ingegno MD; Carlton L; Flynn TC; Seeger JM
    Ann Surg; 1995 May; 221(5):498-503; discussion 503-6. PubMed ID: 7748031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial Femoral Artery Occlusion Reduces Aortofemoral Bypass Graft Patency.
    Tanaka A; Sandhu HK; Perlick A; Miller CC; Saqib NU; Safi HJ; Charlton-Ouw KM
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):650-657. PubMed ID: 30910498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
    Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
    Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular aortoiliac grafts in combination with standard infrainguinal arterial bypasses in the management of limb-threatening ischemia: preliminary report.
    Marin ML; Veith FJ; Sanchez LA; Cynamon J; Suggs WD; Schwartz ML; Parsons RE; Bakal CW; Lyon RT
    J Vasc Surg; 1995 Sep; 22(3):316-24; discussion 324-5. PubMed ID: 7674475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results of aortofemoral bifurcation bypass].
    Hepp W; Ebert C
    Vasa Suppl; 1992; 37():75-7. PubMed ID: 1481110
    [No Abstract]   [Full Text] [Related]  

  • 15. Unilateral aortofemoral bypass: a safe and effective option for the treatment of unilateral limb-threatening ischemia.
    Kram HB; Gupta SK; Veith FJ; Wengerter KR
    Am J Surg; 1991 Aug; 162(2):155-8. PubMed ID: 1862837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Endovascular-First Approach for Aortoiliac Occlusive Disease is Safe: Prior Endovascular Intervention is Not Associated with Inferior Outcomes after Aortofemoral Bypass.
    DeCarlo C; Latz CA; Boitano LT; Mohebali J; Schwartz SI; Eagleton MJ; Clouse WD; Conrad MF
    Ann Vasc Surg; 2021 Jan; 70():62-69. PubMed ID: 32763459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparotomy- and groin-associated complications are common after aortofemoral bypass and contribute to reintervention.
    DeCarlo C; Boitano LT; Schwartz SI; Lancaster RT; Conrad MF; Eagleton MJ; Brewster DC; Clouse WD
    J Vasc Surg; 2020 Dec; 72(6):1976-1986. PubMed ID: 32284209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical analysis of outcome determinants affecting repair of intact aneurysms involving the visceral aorta.
    Back MR; Bandyk M; Bradner M; Cuthbertson D; Johnson BL; Shames ML; Bandyk DF
    Ann Vasc Surg; 2005 Sep; 19(5):648-56. PubMed ID: 16052385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An algorithm for the surgical management of chronic abdominal aortic occlusion and occluded aortofemoral grafts.
    Bowes DE; Youkey JR; Franklin DP; Benoit CH; Pharr WF
    J Cardiovasc Surg (Torino); 1992; 33(6):650-9. PubMed ID: 1287001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of diabetes on arterial reconstructions for multilevel arterial occlusive disease.
    Faries PL; LoGerfo FW; Hook SC; Pulling MC; Akbari CM; Campbell DR; Pomposelli FB
    Am J Surg; 2001 Mar; 181(3):251-5. PubMed ID: 11376581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.